The maillard reaction in eye diseases (Q34436018)

2 August 2017

1 reference

title

The maillard reaction in eye diseases (English)

1 reference

2 August 2017

Alan W Stitt

1

1 reference

PubMed ID

16037281

2 August 2017

language of work or name

English

0 references

publication date

1 June 2005

1 reference

Annals of the New York Academy of Sciences

2 August 2017

1 reference

2 August 2017

1043

1 reference

2 August 2017

582-597

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1338.066

2 August 2017

1 reference

Immunohistochemical localisation of advanced glycation end products in pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1338.066

Maillard reaction products in tissue proteins: new products and new perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1338.066

Formation of glyoxal, methylglyoxal and 3-deoxyglucosone in the glycation of proteins by glucose

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1338.066

The glyoxalase system in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1338.066

Protecting the genome: defence against nucleotide glycation and emerging role of glyoxalase I overexpression in multidrug resistance in cancer chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1338.066

Glyoxalase I deficiency is associated with an unusual level of advanced glycation end products in a hemodialysis patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1338.066

Overexpression of glyoxalase-I in bovine endothelial cells inhibits intracellular advanced glycation endproduct formation and prevents hyperglycemia-induced increases in macromolecular endocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1338.066

Receptors for proteins modified by advanced glycation endproducts (AGE)--their functional role in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1338.066

The biology of the receptor for advanced glycation end products and its ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1338.066

The AGE-receptor in the pathogenesis of diabetic complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1338.066

Molecular identity and cellular distribution of advanced glycation endproduct receptors: relationship of p60 to OST-48 and p90 to 80K-H membrane proteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1338.066

Characterization of the advanced glycation end-product receptor complex in human vascular endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1338.066

Accelerated diabetic glomerulopathy in galectin-3/AGE receptor 3 knockout mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1338.066

Diabetes-associated sustained activation of the transcription factor nuclear factor-kappaB

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1338.066

Blockade of receptor for advanced glycation endproducts: a new target for therapeutic intervention in diabetic complications and inflammatory disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1338.066

Advanced glycation end products in Descemet's membrane and their effect on corneal endothelial cell

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1338.066

Ageing of the human corneal stroma: structural and biochemical changes

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1338.066

Nonenzymatic browning in vivo: possible process for aging of long-lived proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1338.066

Corneal fluorescence in relation to genetic and environmental factors: a twin study

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1338.066

Advanced glycation end-products in corneas of patients with keratoconus

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1338.066

Induction of Cross-links in Corneal Tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1338.066

Epidemiology of age-related cataract

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1338.066

Removal of advanced glycation end products in clinical renal failure by peritoneal dialysis and haemodialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1338.066

Methylglyoxal-derived hydroimidazolone advanced glycation end-products of human lens proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1338.066

2-ammonio-6-(3-oxidopyridinium-1-yl)hexanoate (OP-lysine) is a newly identified advanced glycation end product in cataractous and aged human lenses

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1338.066

The molecular chaperone alpha-crystallin incorporated into red cell ghosts protects membrane Na/K-ATPase against glycation and oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1338.066

Advanced glycation endproducts in human diabetic and non-diabetic cataractous lenses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1338.066

Effect of pyridoxamine on chemical modification of proteins by carbonyls in diabetic rats: characterization of a major product from the reaction of pyridoxamine and methylglyoxal

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1338.066

Cleavage of in vitro and in vivo formed lens protein cross-links by a novel cross-link breaker

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1338.066

Tobacco smoke is a source of toxic reactive glycation products

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1338.066

Cataract formation and prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1338.066

Glycated proteins can enhance photooxidative stress in aged and diabetic lenses

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1338.066

Structural macromolecules and supramolecular organisation of the vitreous gel.

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1338.066

Dynamic light scattering of diabetic vitreopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1338.066

Biochemical abnormalities in vitreous of humans with proliferative diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1338.066

Early drusen formation in the normal and aging eye and their relation to age related maculopathy: a clinicopathological study

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1338.066

An integrated hypothesis that considers drusen as biomarkers of immune-mediated processes at the RPE-Bruch's membrane interface in aging and age-related macular degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1338.066

Drusen-Associated Degeneration in the Retina

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1338.066

Effects of increasing numbers of phagocytic inclusions on human retinal pigment epithelial cells in culture: a model for aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1338.066

Regional variation and age-related changes of lysosomal enzymes in the human retinal pigment epithelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1338.066

The advanced glycation endproduct pentosidine induces the expression of PDGF-B in human retinal pigment epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1338.066

Enhanced binding of advanced glycation endproducts (AGE) by the ApoE4 isoform links the mechanism of plaque deposition in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1338.066

Is amyloid beta-protein glycated in Alzheimer's disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1338.066

Proteins modified by malondialdehyde, 4-hydroxynonenal, or advanced glycation end products in lipofuscin of human retinal pigment epithelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1338.066

Advanced glycation end products increase retinal vascular endothelial growth factor expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1338.066

Characterisation of the advanced glycation endproduct receptor complex in the retinal pigment epithelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1338.066

Alteration of the intracellular pH and apoptosis induction in a retinal cell line by the AGE-inducing agent glyoxal

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1338.066

Experimental induction of AGEs in fetal L132 lung cells changes the level of intracellular cathepsin D.

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1338.066

Accumulation of pyrraline-modified albumin in phagocytes due to reduced degradation by lysosomal enzymes

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1338.066

Biochemical basis of lipofuscin, ceroid, and age pigment-like fluorophores

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1338.066

Optic nerve head structure in glaucoma: astrocytes as mediators of axonal damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1338.066

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1338.066

Changes in the collagenous matrix of the aging human lamina cribrosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1338.066

Effect of aminoguanidine on optic nerve involvement in experimental diabetic rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1338.066

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1338.066

Protein kinase C and the development of diabetic vascular complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1338.066

Expression of transforming growth factor-beta1 and type IV collagen in the renal tubulointerstitium in experimental diabetes: effects of ACE inhibition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1338.066

Possible pathophysiological mechanisms for diabetic angiopathy in type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1338.066

Benfotiamine blocks three major pathways of hyperglycemic damage and prevents experimental diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1338.066

N(epsilon)-(carboxymethyl)lysine levels in patients with type 2 diabetes: role of renal function

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1338.066

Pentosidine formation in skin correlates with severity of complications in individuals with long-standing IDDM

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1338.066

Immunochemical quantification of crossline as a fluorescent advanced glycation endproduct in erythrocyte membrane proteins from diabetic patients with or without retinopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1338.066

Inhibition of advanced glycation end‐products protects against retinal capillary basement membrane expansion during long‐term diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1338.066

Differential accumulation of advanced glycation end products in the course of diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1338.066

High glucose and advanced glycation end products induce phospholipid hydrolysis and phospholipid enzyme inhibition in bovine retinal pericytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1338.066

Modification of enzymatic antioxidants in retinal microvascular cells by glucose or advanced glycation end products.

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1338.066

Advanced glycation endproducts accelerate calcification in microvascular pericytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1338.066

Advanced glycation end products-induced apoptosis and overexpression of vascular endothelial growth factor in bovine retinal pericytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1338.066

Substrates modified by advanced glycation end-products cause dysfunction and death in retinal pericytes by reducing survival signals mediated by platelet-derived growth factor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1338.066

Regulation of vascular endothelial growth factor expression by advanced glycation end products

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1338.066

The Role of Advanced Glycation End Products in Retinal Microvascular Leukostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1338.066

Pathogenetic potential of leukocytes in diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1338.066

Advanced glycation end-products increase monocyte adhesion to retinal endothelial cells through vascular endothelial growth factor-induced ICAM-1 expression: inhibitory effect of antioxidants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1338.066

Aminoguanidine prevents diabetes-induced arterial wall protein cross-linking

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1338.066

Therapeutic potential of breakers of advanced glycation end product–protein crosslinks

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1338.066

Aminoguanidine treatment inhibits the development of experimental diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1338.066

Pharmacological inhibition of diabetic retinopathy: aminoguanidine and aspirin

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1338.066

Randomized trial of an inhibitor of formation of advanced glycation end products in diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1338.066

An agent cleaving glucose-derived protein crosslinks in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1338.066

The cross-link breaker, N-phenacylthiazolium bromide prevents vascular advanced glycation end-product accumulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1338.066

Breakers of advanced glycation end products restore large artery properties in experimental diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1338.066

An advanced glycation endproduct cross-link breaker can reverse age-related increases in myocardial stiffness.

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1338.066

Amadorins: novel post-Amadori inhibitors of advanced glycation reactions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1338.066

A post-Amadori inhibitor pyridoxamine also inhibits chemical modification of proteins by scavenging carbonyl intermediates of carbohydrate and lipid degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1338.066

Chelating activity of advanced glycation end-product inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1338.066

Pyridoxamine inhibits early renal disease and dyslipidemia in the streptozotocin-diabetic rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1338.066

The AGE inhibitor pyridoxamine inhibits development of retinopathy in experimental diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1338.066

Toxic action of advanced glycation end products on cultured retinal capillary pericytes and endothelial cells: relevance to diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1338.066

21 January 2018

Identifiers

DOI

10.1196/ANNALS.1338.066

1 reference

2 August 2017

1 reference

PubMed ID

16037281